Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
Clinical trial NCT00039234 · UNKNOWN
Trial details
- NCT number
- NCT00039234
- Sponsor
- Maxim Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.